Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pre-Eclampsia | 15 | 2018 | 599 | 3.20 | Why? |
| Hypertension, Pregnancy-Induced | 6 | 2018 | 208 | 2.17 | Why? |
| Placenta Growth Factor | 4 | 2018 | 93 | 2.17 | Why? |
| Prenatal Care | 4 | 2020 | 1314 | 0.84 | Why? |
| Maternal-Child Health Services | 1 | 2020 | 124 | 0.75 | Why? |
| Pregnancy | 45 | 2021 | 23879 | 0.73 | Why? |
| Gestational Age | 7 | 2018 | 1488 | 0.73 | Why? |
| Pregnancy Complications, Cardiovascular | 2 | 2018 | 231 | 0.70 | Why? |
| Pregnancy Outcome | 11 | 2021 | 3803 | 0.70 | Why? |
| Protein C | 1 | 2018 | 141 | 0.68 | Why? |
| Early Medical Intervention | 2 | 2018 | 487 | 0.58 | Why? |
| Maternal Health Services | 6 | 2021 | 808 | 0.56 | Why? |
| Mozambique | 7 | 2018 | 205 | 0.54 | Why? |
| Pregnancy Complications | 4 | 2018 | 1388 | 0.54 | Why? |
| Magnesium Sulfate | 3 | 2018 | 52 | 0.53 | Why? |
| Decision Support Techniques | 2 | 2018 | 903 | 0.51 | Why? |
| Blood Pressure | 3 | 2018 | 2198 | 0.45 | Why? |
| Maternal Mortality | 7 | 2018 | 461 | 0.42 | Why? |
| Birth Weight | 4 | 2018 | 250 | 0.40 | Why? |
| Antihypertensive Agents | 2 | 2018 | 1962 | 0.38 | Why? |
| Stillbirth | 5 | 2020 | 544 | 0.38 | Why? |
| Maternal Health | 3 | 2017 | 331 | 0.35 | Why? |
| Pregnancy, High-Risk | 2 | 2018 | 128 | 0.33 | Why? |
| Postpartum Period | 3 | 2018 | 936 | 0.33 | Why? |
| Postpartum Hemorrhage | 2 | 2018 | 144 | 0.32 | Why? |
| Fibrinolytic Agents | 1 | 2018 | 1702 | 0.32 | Why? |
| Fetal Growth Retardation | 2 | 2018 | 217 | 0.30 | Why? |
| Risk Assessment | 6 | 2020 | 25439 | 0.30 | Why? |
| Disability Evaluation | 2 | 2018 | 671 | 0.27 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.25 | Why? |
| Premature Birth | 3 | 2020 | 2151 | 0.24 | Why? |
| Area Under Curve | 3 | 2018 | 2564 | 0.23 | Why? |
| Female | 47 | 2021 | 380317 | 0.21 | Why? |
| Early Diagnosis | 3 | 2018 | 2443 | 0.20 | Why? |
| ROC Curve | 5 | 2018 | 6024 | 0.20 | Why? |
| Infant Health | 2 | 2020 | 160 | 0.19 | Why? |
| Fetal Membranes, Premature Rupture | 2 | 2017 | 122 | 0.19 | Why? |
| Hypertension | 2 | 2018 | 8895 | 0.19 | Why? |
| Infusions, Parenteral | 1 | 2018 | 41 | 0.18 | Why? |
| Rectovaginal Fistula | 1 | 2017 | 7 | 0.18 | Why? |
| Community Health Workers | 3 | 2018 | 468 | 0.18 | Why? |
| Infant, Newborn | 15 | 2021 | 23105 | 0.18 | Why? |
| Biomarkers | 6 | 2018 | 23361 | 0.18 | Why? |
| Vesicovaginal Fistula | 1 | 2017 | 26 | 0.18 | Why? |
| Eclampsia | 1 | 2018 | 38 | 0.18 | Why? |
| Peripartum Period | 1 | 2018 | 89 | 0.18 | Why? |
| Neuroprotection | 1 | 2018 | 62 | 0.17 | Why? |
| Sildenafil Citrate | 1 | 2017 | 66 | 0.17 | Why? |
| Pregnancy Complications, Infectious | 2 | 2020 | 11559 | 0.17 | Why? |
| Prenatal Exposure Delayed Effects | 2 | 2018 | 319 | 0.17 | Why? |
| Phosphodiesterase 5 Inhibitors | 1 | 2017 | 104 | 0.16 | Why? |
| Hospitals, Private | 1 | 2018 | 198 | 0.16 | Why? |
| Reagent Strips | 1 | 2017 | 129 | 0.16 | Why? |
| Obstetric Labor Complications | 1 | 2017 | 119 | 0.16 | Why? |
| British Columbia | 1 | 2018 | 512 | 0.16 | Why? |
| Cerebral Palsy | 1 | 2018 | 156 | 0.16 | Why? |
| United Kingdom | 4 | 2021 | 18046 | 0.15 | Why? |
| Technology Assessment, Biomedical | 1 | 2017 | 106 | 0.15 | Why? |
| Infant Mortality | 4 | 2020 | 268 | 0.15 | Why? |
| Vital Signs | 1 | 2018 | 257 | 0.15 | Why? |
| Prenatal Diagnosis | 1 | 2018 | 345 | 0.15 | Why? |
| Neuroprotective Agents | 1 | 2018 | 240 | 0.14 | Why? |
| Prognosis | 5 | 2018 | 32490 | 0.14 | Why? |
| Blood Pressure Determination | 1 | 2018 | 450 | 0.14 | Why? |
| Urban Health | 1 | 2017 | 382 | 0.14 | Why? |
| Predictive Value of Tests | 3 | 2018 | 9537 | 0.13 | Why? |
| Child Development | 1 | 2018 | 352 | 0.13 | Why? |
| Community Health Services | 3 | 2018 | 1000 | 0.13 | Why? |
| Proteinuria | 1 | 2017 | 474 | 0.13 | Why? |
| Humans | 47 | 2021 | 930598 | 0.12 | Why? |
| Practice Guidelines as Topic | 2 | 2017 | 15421 | 0.12 | Why? |
| Equipment and Supplies | 1 | 2018 | 440 | 0.12 | Why? |
| Adult | 22 | 2021 | 244371 | 0.12 | Why? |
| Anticonvulsants | 1 | 2018 | 634 | 0.12 | Why? |
| Young Adult | 12 | 2018 | 93724 | 0.12 | Why? |
| Emergency Treatment | 1 | 2018 | 719 | 0.12 | Why? |
| Hospitals, Public | 1 | 2018 | 774 | 0.12 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.11 | Why? |
| Delivery, Obstetric | 2 | 2018 | 1292 | 0.11 | Why? |
| Risk Factors | 7 | 2020 | 71621 | 0.11 | Why? |
| Weather | 1 | 2017 | 581 | 0.11 | Why? |
| Gynecology | 1 | 2018 | 741 | 0.11 | Why? |
| Pregnant Women | 2 | 2021 | 2535 | 0.11 | Why? |
| Evidence-Based Practice | 1 | 2017 | 693 | 0.11 | Why? |
| Demography | 1 | 2018 | 1660 | 0.11 | Why? |
| Transportation | 1 | 2017 | 691 | 0.10 | Why? |
| Biological Specimen Banks | 1 | 2018 | 1142 | 0.10 | Why? |
| Obstetrics | 1 | 2018 | 859 | 0.10 | Why? |
| Social Class | 1 | 2018 | 1360 | 0.10 | Why? |
| Netherlands | 1 | 2018 | 3533 | 0.09 | Why? |
| Rural Population | 2 | 2018 | 2408 | 0.09 | Why? |
| Logistic Models | 3 | 2018 | 9089 | 0.09 | Why? |
| Infant, Small for Gestational Age | 2 | 2018 | 151 | 0.09 | Why? |
| Canada | 2 | 2018 | 6018 | 0.09 | Why? |
| Recombinant Proteins | 1 | 2018 | 3786 | 0.09 | Why? |
| Health Resources | 2 | 2018 | 2592 | 0.09 | Why? |
| Feasibility Studies | 4 | 2018 | 3467 | 0.09 | Why? |
| Income | 1 | 2017 | 1564 | 0.08 | Why? |
| Morbidity | 3 | 2018 | 1426 | 0.08 | Why? |
| Reproducibility of Results | 3 | 2018 | 11304 | 0.08 | Why? |
| Pregnancy Trimester, Third | 2 | 2018 | 445 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.08 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.08 | Why? |
| Patient Acceptance of Health Care | 3 | 2020 | 5002 | 0.08 | Why? |
| Qualitative Research | 4 | 2021 | 4337 | 0.08 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.08 | Why? |
| Primary Health Care | 3 | 2018 | 4839 | 0.07 | Why? |
| Survival Rate | 2 | 2017 | 9206 | 0.07 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.07 | Why? |
| Parturition | 2 | 2021 | 514 | 0.07 | Why? |
| Health Status | 1 | 2018 | 3259 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Focus Groups | 2 | 2018 | 811 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.06 | Why? |
| Information Dissemination | 1 | 2018 | 2986 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.06 | Why? |
| Prospective Studies | 5 | 2020 | 43301 | 0.06 | Why? |
| Decision Making | 1 | 2016 | 3132 | 0.06 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.06 | Why? |
| Emergency Medical Services | 1 | 2018 | 3557 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.05 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.05 | Why? |
| Brazil | 4 | 2018 | 12582 | 0.05 | Why? |
| India | 4 | 2018 | 11875 | 0.05 | Why? |
| Nigeria | 2 | 2018 | 2292 | 0.05 | Why? |
| Adrenal Cortex Hormones | 1 | 2017 | 6537 | 0.05 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.05 | Why? |
| Fetal Macrosomia | 1 | 2018 | 16 | 0.05 | Why? |
| Health Facilities | 2 | 2018 | 1230 | 0.05 | Why? |
| Pakistan | 2 | 2017 | 2302 | 0.05 | Why? |
| Retrospective Studies | 7 | 2018 | 105322 | 0.05 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.05 | Why? |
| Labor Stage, First | 1 | 2017 | 5 | 0.04 | Why? |
| Pregnancy Trimesters | 1 | 2018 | 90 | 0.04 | Why? |
| Research Design | 3 | 2020 | 5830 | 0.04 | Why? |
| Incidence | 2 | 2017 | 25622 | 0.04 | Why? |
| Glasgow Coma Scale | 1 | 2018 | 249 | 0.04 | Why? |
| Autoanalysis | 1 | 2017 | 2 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Child | 4 | 2020 | 70012 | 0.04 | Why? |
| Umbilical Arteries | 1 | 2017 | 62 | 0.04 | Why? |
| Fiji | 1 | 2017 | 31 | 0.04 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.04 | Why? |
| Infant | 5 | 2018 | 30274 | 0.04 | Why? |
| Uterine Hemorrhage | 1 | 2017 | 73 | 0.04 | Why? |
| Global Health | 1 | 2021 | 13911 | 0.04 | Why? |
| South Africa | 2 | 2018 | 3326 | 0.04 | Why? |
| Parity | 1 | 2017 | 122 | 0.04 | Why? |
| Amnion | 1 | 2016 | 55 | 0.04 | Why? |
| Hypothalamo-Hypophyseal System | 1 | 2018 | 187 | 0.04 | Why? |
| Sodium | 1 | 2018 | 309 | 0.04 | Why? |
| Obstetric Labor, Premature | 1 | 2017 | 114 | 0.04 | Why? |
| Health Services Accessibility | 2 | 2017 | 10697 | 0.04 | Why? |
| Nepal | 1 | 2020 | 1004 | 0.04 | Why? |
| Maternal Age | 1 | 2017 | 244 | 0.04 | Why? |
| Africa South of the Sahara | 1 | 2020 | 1335 | 0.04 | Why? |
| Evaluation Studies as Topic | 1 | 2017 | 391 | 0.04 | Why? |
| Bilirubin | 1 | 2018 | 503 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Women's Health | 1 | 2020 | 444 | 0.04 | Why? |
| Reference Values | 1 | 2018 | 795 | 0.04 | Why? |
| Rural Health | 1 | 2017 | 243 | 0.04 | Why? |
| World Health Organization | 2 | 2018 | 4213 | 0.04 | Why? |
| Intensive Care Units | 2 | 2018 | 29594 | 0.03 | Why? |
| Perinatal Death | 1 | 2016 | 372 | 0.03 | Why? |
| Probability | 1 | 2017 | 923 | 0.03 | Why? |
| Uganda | 1 | 2017 | 1057 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.03 | Why? |
| Poverty Areas | 1 | 2018 | 556 | 0.03 | Why? |
| Patient Reported Outcome Measures | 1 | 2018 | 912 | 0.03 | Why? |
| Walking | 1 | 2017 | 442 | 0.03 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.03 | Why? |
| Abortion, Spontaneous | 1 | 2018 | 776 | 0.03 | Why? |
| Interviews as Topic | 1 | 2021 | 1952 | 0.03 | Why? |
| False Positive Reactions | 1 | 2017 | 1338 | 0.03 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.03 | Why? |
| New Zealand | 1 | 2018 | 2073 | 0.03 | Why? |
| Cesarean Section | 1 | 2021 | 2089 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Intensive Care Units, Neonatal | 1 | 2016 | 749 | 0.03 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.02 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Health Care Surveys | 1 | 2018 | 2942 | 0.02 | Why? |
| Needs Assessment | 1 | 2018 | 2352 | 0.02 | Why? |
| Environmental Exposure | 1 | 2018 | 1558 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Equipment Design | 1 | 2018 | 3095 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Odds Ratio | 1 | 2016 | 5861 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.02 | Why? |
| Male | 6 | 2018 | 367725 | 0.02 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2016 | 8495 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.01 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Middle Aged | 3 | 2018 | 270681 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
von Dadelszen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(208)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(38)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_